.png)
.png)
Institute for Clinical Pharmacodynamics
Disclosure(s): Adagio Therapeutics, Inc.: Grant/Research Support; Amplyx Pharmaceuticals, Inc.: Grant/Research Support; AN2 Therapeutics: Grant/Research Support; Antabio SAS: Grant/Research Support; Arcutis Biotherapeutics, Inc.: Grant/Research Support; B. Braun Medical Inc.: Grant/Research Support; Basilea Pharmaceutica: Grant/Research Support; Boston Pharmaceuticals: Grant/Research Support; Celdara Medical LLC: Grant/Research Support; Cidara Therapeutics Inc.: Grant/Research Support; Cipla USA: Grant/Research Support; Crestone Inc.: Grant/Research Support; CXC: Grant/Research Support; Debiopharm International SA: Grant/Research Support; Entasis Therapeutics: Grant/Research Support; Evopoint Biosciences Co.: Grant/Research Support; Fedora Pharmaceuticals: Grant/Research Support; GlaxoSmithKline: Grant/Research Support; Hoffmann-La Roche: Grant/Research Support; Insmed Inc.: Grant/Research Support; Iterum Therapeutics Limited: Grant/Research Support; Kaizen Bioscience, Co.: Grant/Research Support; KBP Biosciences USA: Grant/Research Support; Lassen Therapeutics: Grant/Research Support; Matinas Biopharma: Grant/Research Support; Meiji Seika Pharma Co., Ltd.: Grant/Research Support; Melinta Therapeutics: Grant/Research Support; Menarini Ricerche S.p.A.: Grant/Research Support; Mutabilis: Grant/Research Support; Nabriva Therapeutics AG: Grant/Research Support; Novartis Pharmaceuticals Corp.: Grant/Research Support; Paratek Pharmaceuticals, Inc.: Grant/Research Support; PureTech Health: Grant/Research Support; Sfunga Therapeutics: Grant/Research Support; Spero Therapeutics: Grant/Research Support; Suzhou Sinovent Pharmaceuticals Co.: Grant/Research Support; TauRx Therapeutics: Grant/Research Support; Tetraphase Pharmaceuticals: Grant/Research Support; tranScrip Partners: Grant/Research Support; Utility Therapeutics: Grant/Research Support; Valanbio Therapeutics, Inc.: Grant/Research Support; VenatoRx: Grant/Research Support; Wockhardt Bio AG: Grant/Research Support